X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (72407) 72407
Book Review (10895) 10895
Publication (8443) 8443
Book Chapter (323) 323
Conference Proceeding (187) 187
Book / eBook (156) 156
Government Document (127) 127
Newsletter (70) 70
Newspaper Article (56) 56
Magazine Article (41) 41
Dissertation (21) 21
Paper (7) 7
Data Set (5) 5
Reference (5) 5
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (69215) 69215
humans (67115) 67115
female (44846) 44846
breast cancer (25147) 25147
oncology (23519) 23519
animals (22338) 22338
cancer (21690) 21690
biochemistry & molecular biology (20419) 20419
cell line, tumor (20193) 20193
breast neoplasms - pathology (19550) 19550
breast-cancer (18108) 18108
breast neoplasms - metabolism (13713) 13713
middle aged (13501) 13501
mice (13036) 13036
cell biology (12506) 12506
expression (12148) 12148
breast neoplasms - genetics (11432) 11432
adult (10558) 10558
male (10459) 10459
aged (10426) 10426
breast neoplasms - drug therapy (10349) 10349
tumors (9851) 9851
apoptosis (9683) 9683
metastasis (9405) 9405
research (9133) 9133
gene expression (7793) 7793
gene expression regulation, neoplastic (7592) 7592
proteins (7419) 7419
prognosis (7331) 7331
immunohistochemistry (6992) 6992
analysis (6885) 6885
tumor cells, cultured (6768) 6768
article (6465) 6465
breast neoplasms - chemistry (6349) 6349
antineoplastic agents - pharmacology (6214) 6214
genetic aspects (6208) 6208
cells (6127) 6127
chemotherapy (5824) 5824
signal transduction (5786) 5786
carcinoma (5785) 5785
health aspects (5694) 5694
care and treatment (5415) 5415
research article (5391) 5391
pharmacology & pharmacy (5378) 5378
breast (5265) 5265
medicine (5261) 5261
genetics & heredity (5055) 5055
cell proliferation (4968) 4968
cell proliferation - drug effects (4847) 4847
apoptosis - drug effects (4791) 4791
growth (4672) 4672
development and progression (4311) 4311
aged, 80 and over (4177) 4177
mcf-7 cells (4124) 4124
pathology (4121) 4121
mice, nude (4065) 4065
multidisciplinary sciences (4049) 4049
risk factors (3973) 3973
in-vitro (3928) 3928
activation (3875) 3875
mutation (3870) 3870
gene-expression (3854) 3854
physiological aspects (3822) 3822
phosphorylation (3818) 3818
biochemistry (3797) 3797
genes (3716) 3716
therapy (3702) 3702
biology (3684) 3684
in-vivo (3499) 3499
biomarkers, tumor - analysis (3462) 3462
survival (3447) 3447
neoplasms - metabolism (3431) 3431
neoplasm metastasis (3406) 3406
neoplasms - drug therapy (3351) 3351
antineoplastic agents - therapeutic use (3336) 3336
neoplasms - pathology (3327) 3327
protein (3317) 3317
science (3304) 3304
cancer research (3243) 3243
cell cycle (3207) 3207
prostate-cancer (3190) 3190
neoplasm invasiveness (3156) 3156
cancer therapies (3144) 3144
proliferation (3139) 3139
kinases (3114) 3114
biophysics (3098) 3098
inhibition (3093) 3093
molecular sequence data (3083) 3083
medicine, research & experimental (3071) 3071
estrogen (3058) 3058
breast-cancer cells (3007) 3007
gene (3006) 3006
chemistry, medicinal (3000) 3000
cell survival - drug effects (2990) 2990
cancer cells (2966) 2966
blotting, western (2946) 2946
neoplasms - genetics (2882) 2882
neoplasm staging (2857) 2857
receptors, estrogen - analysis (2853) 2853
mice, inbred balb c (2792) 2792
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (129) 129
Collection Dvlpm't (Acquisitions) - Closed Orders (13) 13
Collection Dvlpm't (Acquisitions) - Vendor file (7) 7
Mt Sinai Hospital - Pathology (4) 4
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Humber River Regional Hospital - Finch Stacks (2) 2
Lakeridge Health Sciences - Oshawa (2) 2
Markham Stouffville Hospital - Stacks (2) 2
New College (Ivey) - Stacks (2) 2
UTL at Downsview - May be requested (2) 2
Credit Valley Hospital - Reference (1) 1
Gerstein Science - Circulation Desk (1) 1
Gerstein Science - Not Returned (1) 1
Gerstein Science - Reference (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Reference (1) 1
Scarborough Hospital - General (1) 1
St Josephs Health Centre - Stacks (1) 1
Trinity College (John W Graham) - Storage (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (71944) 71944
Chinese (214) 214
French (207) 207
Japanese (136) 136
Russian (90) 90
Spanish (80) 80
German (69) 69
Italian (53) 53
Hungarian (34) 34
Polish (28) 28
Czech (17) 17
Portuguese (11) 11
Romanian (7) 7
Dutch (6) 6
Serbian (5) 5
Croatian (4) 4
Bulgarian (3) 3
Danish (3) 3
Swedish (3) 3
Ukrainian (3) 3
Hebrew (2) 2
Norwegian (2) 2
Lithuanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2011, Volume 12, Issue 9, pp. 852 - 861
Summary Background Olaparib (AZD2281) is a small-molecule, potent oral poly(ADP-ribose) polymerase (PARP) inhibitor. We aimed to assess the safety and... 
Hematology, Oncology and Palliative Medicine | POLY(ADP-RIBOSE) POLYMERASE | BRCA2 MUTATIONS | LIPOSOMAL DOXORUBICIN | RIBOSE POLYMERASE INHIBITORS | SOLID TUMORS | ONCOLOGY | GENETICS | GUIDELINES | SENSITIVITY | RESISTANCE | PARP INHIBITOR | Humans | Middle Aged | Ovarian Neoplasms - pathology | Carcinoma - mortality | Antineoplastic Agents - therapeutic use | Antineoplastic Agents - administration & dosage | Enzyme Inhibitors - administration & dosage | Ovarian Neoplasms - genetics | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Time Factors | Aged, 80 and over | Cell Differentiation | Carcinoma - drug therapy | Enzyme Inhibitors - adverse effects | Phthalazines - administration & dosage | Administration, Oral | Piperazines - therapeutic use | Breast Neoplasms - drug therapy | Enzyme Inhibitors - therapeutic use | Piperazines - adverse effects | Poly(ADP-ribose) Polymerase Inhibitors | Ovarian Neoplasms - enzymology | Canada | Breast Neoplasms - genetics | Carcinoma - genetics | Mutation | Receptor, ErbB-2 - analysis | Piperazines - administration & dosage | Receptors, Estrogen - analysis | Ovarian Neoplasms - mortality | Breast Neoplasms - enzymology | Antineoplastic Agents - adverse effects | Carcinoma - enzymology | Adult | Female | Ovarian Neoplasms - drug therapy | Carcinoma - secondary | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Treatment Outcome | BRCA1 Protein - genetics | Disease-Free Survival | Phthalazines - therapeutic use | Poly(ADP-ribose) Polymerases - metabolism | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | BRCA2 Protein - genetics | Phthalazines - adverse effects | Care and treatment | Relapse | Gene mutations | Oncology, Experimental | Breast cancer | Research | Cancer | Diseases | Index Medicus
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2015, Volume 107, Issue 6, pp. djv048 - djv048
Background: The American Cancer Society (ACS), Centers for Disease Control and Prevention (CDC), National Cancer Institute (NCI), and North American... 
INCIDENCE RATES | SPECIAL SECTION | LUNG-CANCER | AGE-SPECIFIC INCIDENCE | INCREASING INCIDENCE | SURVEILLANCE DATA | ONCOLOGY | RECEPTOR STATUS | THYROID-CANCER | TRENDS | SOCIOECONOMIC-STATUS | United States - epidemiology | Age Distribution | Prognosis | Early Detection of Cancer - methods | Humans | Middle Aged | Hispanic Americans - statistics & numerical data | Male | Receptors, Estrogen - analysis | Incidence | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Aged, 80 and over | Adult | Female | Registries | Breast Neoplasms, Male - epidemiology | Mammography - statistics & numerical data | Breast Neoplasms - ethnology | Early Detection of Cancer - statistics & numerical data | Breast Neoplasms - epidemiology | Ethnic Groups - statistics & numerical data | Poverty | Mammography - trends | Biomarkers, Tumor - analysis | European Continental Ancestry Group - statistics & numerical data | African Americans - statistics & numerical data | Confounding Factors (Epidemiology) | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Breast Neoplasms - diagnosis | Breast Neoplasms, Male - pathology | Receptor, ErbB-2 - analysis | Neoplasm Staging | Continental Population Groups - statistics & numerical data | Forecasts and trends | Demographic aspects | Distribution | Cancer | Biomarkers | Breast cancer | Mammography | Hormones | Correlation analysis | Tumors | Index Medicus
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2012, Volume 48, Issue 18, pp. 3342 - 3354
Journal Article
American Journal of Surgical Pathology, ISSN 0147-5185, 03/2012, Volume 36, Issue 3, pp. 343 - 350
To determine the influence of the newly described mammary analog secretory carcinoma (MASC) with ETV6 translocation on our understanding of salivary acinic... 
mammary analog | acinic | high-grade transformation | ETV6 | SURGERY | PAROTID-GLAND | ADENOCARCINOMA | PATHOLOGY | SALIVARY-GLAND ORIGIN | TUMORS | BREAST | Immunohistochemistry | Predictive Value of Tests | Translocation, Genetic | Breast Neoplasms - secondary | Proto-Oncogene Proteins c-ets - genetics | Salivary Gland Neoplasms - genetics | Humans | Middle Aged | Male | Carcinoma - chemistry | Breast Neoplasms - therapy | Breast Neoplasms - chemistry | Carcinoma, Acinar Cell - secondary | Time Factors | Female | Carcinoma - secondary | Diagnosis, Differential | Carcinoma, Acinar Cell - chemistry | Secretory Vesicles - chemistry | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Neoplasm Recurrence, Local | Repressor Proteins - genetics | Carcinoma - diagnosis | In Situ Hybridization, Fluorescence | Survival Rate | Treatment Outcome | Carcinoma, Acinar Cell - genetics | Lymphatic Metastasis | Salivary Gland Neoplasms - diagnosis | Salivary Gland Neoplasms - chemistry | Breast Neoplasms - genetics | Diagnostic Errors - prevention & control | Carcinoma, Acinar Cell - diagnosis | Salivary Gland Neoplasms - therapy | Carcinoma - genetics | Carcinoma - therapy | Secretory Vesicles - pathology | Breast Neoplasms - diagnosis | Neoplasm Staging | Salivary Gland Neoplasms - pathology | Carcinoma, Acinar Cell - therapy | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 13, pp. 1269 - 1277
Journal Article
Breast Cancer Research, ISSN 1465-5411, 08/2009, Volume 11, Issue 4, pp. R59 - R59
Introduction The role of circulating tumor cells (CTCs) in blood of primary breast cancer patients is still under investigation. We evaluated the incidence of... 
CYTOKERATIN-POSITIVE CELLS | ADJUVANT CHEMOTHERAPY | MICROMETASTATIC CARCINOMA-CELLS | POLYMERASE-CHAIN-REACTION | ONCOLOGY | HER2 STATUS | PERIPHERAL-BLOOD | STAGE-I | PROGNOSTIC VALUE | ESTROGEN-RECEPTOR | CLINICAL-SIGNIFICANCE | Adenocarcinoma - pathology | Estrogens | Humans | Receptors, Estrogen - analysis | Neoplastic Stem Cells - chemistry | Epithelial Cell Adhesion Molecule | Bone Marrow Neoplasms - ultrastructure | Neoplasm, Residual | Receptors, Progesterone - analysis | Breast Neoplasms - chemistry | Keratins - analysis | Mucin-1 - analysis | Neoplasms, Hormone-Dependent - chemistry | Female | Antigens, Neoplasm - analysis | Chemotherapy, Adjuvant | Biomarkers, Tumor - analysis | Adenocarcinoma - blood | Neoplastic Cells, Circulating - chemistry | Reverse Transcriptase Polymerase Chain Reaction | Breast Neoplasms - drug therapy | Bone Marrow Neoplasms - secondary | Neoplasms, Hormone-Dependent - blood | Breast Neoplasms - pathology | Neoplasms, Hormone-Dependent - pathology | Bone Marrow - pathology | Breast Neoplasms - blood | Cell Adhesion Molecules - analysis | Neoplasm Proteins - analysis | Progesterone | Receptor, ErbB-2 - analysis | Polymerase chain reaction | Care and treatment | Usage | Cancer cells | Physiological aspects | Development and progression | Breast cancer | Genetic aspects | Research | Gene expression | Index Medicus
Journal Article